APA (7th ed.) Citation

Persson, F., Rossing, P., Vart, P., Chertow, G. M., Hou, F. F., Jongs, N., . . . Heerspink, H. J. (2021). Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial. Diabetes care, 44(8), 1894-1897. https://doi.org/10.2337/dc21-0300

Chicago Style (17th ed.) Citation

Persson, Frederik, et al. "Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial." Diabetes Care 44, no. 8 (2021): 1894-1897. https://doi.org/10.2337/dc21-0300.

MLA (9th ed.) Citation

Persson, Frederik, et al. "Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial." Diabetes Care, vol. 44, no. 8, 2021, pp. 1894-1897, https://doi.org/10.2337/dc21-0300.